Pfizer Inc. (PFE)
The income statement presents information on the financial results of a company’s business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
Pfizer Inc., Consolidated Income Statement
USD $ in millions
|Revenues||Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.||Pfizer Inc.’s revenues declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.|
|Operating income||The net result for the period of deducting operating expenses from operating revenues.||Pfizer Inc.’s operating income increased from 2016 to 2017 and from 2017 to 2018.|
|Income from continuing operations before (provision) benefit for taxes on income||Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.||Pfizer Inc.’s income from continuing operations before (provision) benefit for taxes on income increased from 2016 to 2017 but then slightly declined from 2017 to 2018.|
|Net income attributable to Pfizer Inc.||The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.||Pfizer Inc.’s net income attributable to Pfizer Inc. increased from 2016 to 2017 but then slightly declined from 2017 to 2018 not reaching 2016 level.|